{"nct_id":"NCT05217472","title":"An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)","status":"WITHDRAWN","status_verified_date":"2020-02","start_date":"2020-03-06","start_date_type":"ESTIMATED","primary_completion_date":"2022-04-15","primary_completion_date_type":"ESTIMATED","completion_date":"2022-05-15","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}